Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
30
Number of overlapping holdings
13.4%
% of IBB's 261 holdings also in IDNA
65.2%
% of IDNA's 51 holdings also in IBB
Overlap by Weight
Sector Drift (IBB minus IDNA)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IBB |
Weight in IDNA |
Overlap | |
|---|---|---|---|---|
 |
REGENERON PHARMACEUTICALS | 7.3% | 4.0% | 4.0% |
 |
BIONTECH SE SPONSORED ADR | 2.0% | 4.0% | 2.0% |
|
INCYTE CORP | 1.3% | 4.2% | 1.3% |
|
MODERNA, INC. | 1.2% | 3.6% | 1.2% |
|
EXELIXIS INC | 1.1% | 4.8% | 1.1% |
Position Highlights (Non-Overlapping Exposures)
IBB Overweight Relative to IDNA
|
GILEAD SCIENCES INC | 10.6% |
|
AMGEN INC | 9.6% |
|
VERTEX PHARMACEUTICALS INC | 8.7% |
|
IQVIA HOLDINGS INC | 3.4% |
|
REGENERON PHARMACEUTICALS | 3.3% |
|
ALNYLAM PHARMACEUTICALS INC | 3.1% |
 |
ARGENX SE ADR | 2.7% |
 |
METTLER-TOLEDO INTERNATIONAL | 2.6% |
|
WATERS CORP | 2.3% |
|
BIOGEN IDEC INC | 2.1% |
IBB Underweight Relative to IDNA
 |
BEIGENE, LTD. | -5.5% |
 |
SANOFI-AVENTIS | -5.4% |
|
ROCHE HOLDING LTD | -5.3% |
 |
GSK PLC | -5.1% |
|
ASTRAZENECA PLC | -5.1% |
 |
GENMAB A/S | -4.9% |
 |
TAKEDA PHARMACEUTICAL CO LTD | -4.6% |
|
SPRINGWORKS THERAPEUTICS, INC. | -4.5% |
|
MERCK & CO. INC. | -4.1% |
|
EXELIXIS INC | -3.7% |